Pharma Foods International Co., Ltd. provided consolidated earnings guidance for the year ending July 31, 2023. For the year, the company expects net sales of ¥71,000 million, operating profit of ¥1,191 million, profit attributable to owners of the parent of ¥886 million, and earnings per share of ¥30.47.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
868 JPY | +1.76% | +2.97% | -13.37% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.37% | 155M | |
+22.93% | 46.4B | |
-1.50% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+9.98% | 26.01B | |
-19.10% | 19.52B | |
+30.18% | 12.43B | |
-0.30% | 12.18B | |
-0.83% | 12.13B |
- Stock Market
- Equities
- 2929 Stock
- News Pharma Foods International Co., Ltd.
- Pharma Foods International Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending July 31, 2023